Literature DB >> 8531178

Activation of the renin-angiotensin system in dogs with asymptomatic and mildly symptomatic mitral valvular insufficiency.

H D Pedersen1, J Koch, K Poulsen, A L Jensen, A Flagstad.   

Abstract

The renin-angiotensin system has important pathophysiologic implications in the development of congestive heart failure. The activity of the renin-angiotensin system early in the course of heart disease and heart failure in dogs was evaluated by measuring the plasma renin activity (PRA) and plasma aldosterone concentration (PAC) in 18 Cavalier King Charles Spaniels with asymptomatic or mildly symptomatic mitral valvular insufficiency, and in 18 healthy Cavalier King Charles Spaniels. All dogs were unmedicated and had no other diseases. The PRA was high in the dogs with mitral valvular insufficiency (median 3.44 ng/mL/h, interquartile interval 2.59 to 8.66 ng/mL/h) compared with the controls (median 2.51 ng/mL/h, interquartile interval 1.44 to 3.58 ng/mL/h). The PAC was also higher in the dogs with mitral insufficiency (median 53 pg/mL, interquartile interval 33 to 138 pg/mL) than in the control group (median 27 pg/mL, interquartile interval 11.5 to 54 pg/mL). However, there was considerable overlap between the 2 groups in both PRA and PAC. It was concluded from these data that there is early activation of the renin-angiotensin system in some Cavalier King Charles Spaniels with mitral valvular insufficiency. Further prospective studies are needed to determine if early intervention with angiotensin-converting enzyme inhibitors will be valuable in this group of patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8531178     DOI: 10.1111/j.1939-1676.1995.tb01092.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  9 in total

1.  Effects of mild mitral valve insufficiency, sodium intake, and place of blood sampling on the renin-angiotensin system in dogs.

Authors:  H D Pedersen
Journal:  Acta Vet Scand       Date:  1996       Impact factor: 1.695

2.  Endogenous angiotensin II has fewer effects but neuronal nitric oxide synthase has excitatory effects on renal sympathetic nerve activity in salt-sensitive hypertension-induced heart failure.

Authors:  Takehito Kemuriyama; Megumi Tandai-Hiruma; Kazuo Kato; Hiroyuki Ohta; Satoshi Maruyama; Yoshiaki Sato; Yasuhiro Nishida
Journal:  J Physiol Sci       Date:  2009-03-28       Impact factor: 2.781

3.  Plasma and tissue angiotensin-converting enzyme 2 activity and plasma equilibrium concentrations of angiotensin peptides in dogs with heart disease.

Authors:  Éva Larouche-Lebel; Kerry A Loughran; Mark A Oyama; Phil F Solter; Danielle S Laughlin; Melissa D Sánchez; Charles-Antoine Assenmacher; Philip R Fox; Ryan C Fries
Journal:  J Vet Intern Med       Date:  2019-06-28       Impact factor: 3.333

4.  Effect of angiotensin receptor blockers and angiotensin converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in dogs with heart disease.

Authors:  Éva Larouche-Lebel; Kerry A Loughran; Terry Huh; Mark A Oyama
Journal:  J Vet Intern Med       Date:  2020-12-24       Impact factor: 3.175

5.  Factors affecting the urinary aldosterone-to-creatinine ratio in healthy dogs and dogs with naturally occurring myxomatous mitral valve disease.

Authors:  Alberto Galizzi; Mara Bagardi; Angelica Stranieri; Anna Maria Zanaboni; Dario Malchiodi; Vitaliano Borromeo; Paola Giuseppina Brambilla; Chiara Locatelli
Journal:  BMC Vet Res       Date:  2021-01-07       Impact factor: 2.741

Review 6.  COVID-19: imbalance of multiple systems during infection and importance of therapeutic choice and dosing of cardiac and anti-coagulant therapies.

Authors:  Habib Haybar; Mahmood Maniati; Najmaldin Saki; Zeinab Deris Zayeri
Journal:  Mol Biol Rep       Date:  2021-04-10       Impact factor: 2.316

7.  Changes in renin-angiotensin-aldosterone system during cardiac remodeling after mitral valvuloplasty in dogs.

Authors:  Chieh-Jen Cheng; Ahmed S Mandour; Tomohiko Yoshida; Toshihiro Watari; Ryou Tanaka; Katsuhiro Matsuura
Journal:  J Vet Intern Med       Date:  2022-01-07       Impact factor: 3.333

8.  Effects of the angiotensin-converting enzyme inhibitor alacepril in dogs with mitral valve disease.

Authors:  Yasutomo Hori; Kensuke Nakamura; Nobuyuki Kanno; Makoto Hitomi; Yohei Yamashita; Satoshi Hosaka; Noriko Isayama; Takahiro Mimura
Journal:  J Vet Med Sci       Date:  2018-06-22       Impact factor: 1.267

9.  Correction of serum chloride concentration in dogs with congestive heart failure.

Authors:  Darcy Adin; Clarke Atkins; Leonel Londoño; Bruna Del Nero
Journal:  J Vet Intern Med       Date:  2020-12-11       Impact factor: 3.175

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.